Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients

Eli Lilly and Co. LLY on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for Retevmo ...
24/7 Wall St.

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

A prior version of this article stated Eli Lilly and Nvidia had funded a supercomputer, when the commitment was for the co-innovation lab. This article has been updated to reflect the change. If there ...